|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1Department of Cellular and Molecular Medicine and 2Ottawa Hospital and Ottawa Health Research Institute, University of Ottawa, Ottawa, Canada; and 3Division of Cellular and Molecular Medicine, Graduate School of Medicine, Kobe University, Kobe, Japan
Submitted 15 May 2007 ; accepted in final form 9 November 2007
In wild-type mice, a single injection of streptozotocin (STZ, 200 mg/kg body wt) caused within 4 days severe hyperglycemia, hypoinsulinemia, significant glucose intolerance, loss of body weight, and the disappearance of pancreatic β-cells. However, in ATP-sensitive K+ channel (KATP channel)-deficient mice (Kir6.2–/– mice), STZ had none of these effects. Exposing isolated pancreatic islets to STZ caused severe damage in wild-type but not in Kir6.2–/– islets. Following a single injection, plasma STZ levels were slightly less in Kir6.2–/– mice than in wild-type mice. Despite the difference in plasma STZ, wild-type and Kir6.2–/– liver accumulated the same amount of STZ, whereas Kir6.2–/– pancreas accumulated 4.1-fold less STZ than wild-type pancreas. Kir6.2–/– isolated pancreatic islets also transported less glucose than wild-type ones. Quantification of glucose transporter 2 (GLUT2) protein content by Western blot using an antibody with an epitope in the extracellular loop showed no significant difference in GLUT2 content between wild-type and Kir6.2–/– pancreatic islets. However, visualization by immunofluorescence with the same antibody gave rise to 32% less fluorescence in Kir6.2–/– pancreatic islets. The fluorescence intensity using another antibody, with an epitope in the COOH terminus, was 5.6 times less in Kir6.2–/– than in wild-type pancreatic islets. We conclude that 1) Kir6.2–/– mice are STZ resistant because of a decrease in STZ transport by GLUT2 in pancreatic β-cells and 2) the decreased transport is due to a downregulation of GLUT2 activity involving an effect at the COOH terminus.
knockout; insulin; liver; glucose transporter; glucose tolerance; diabetic model
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |